Search Results

• • 14 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Everolimus-based therapy in patients with hormone receptor-positive, HER2.sup.- advanced breast cancer: management considerations

  Authors:Lucia Del Mastro, Marina Cazzaniga, Paolo Solidoro, Daniele Generali, Giulia Bianchi, Franco Testore, et al.From:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20152,209 words Report 1660LAuthor(s): Lucia Del Mastro aff1 , Marina Cazzaniga aff2 , Paolo Solidoro aff3 , Daniele Generali aff4 , Giulia Bianchi aff5 , Franco Testore aff6 , Sabino De Placido [*] aff7 KEYWORDS adverse events; breast...

• Anti-PD-1 and PD-L1 therapy for bladder cancer: what is on the horizon?

  Authors:Srinath Sundararajan and Nicholas J VogelzangFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20155,409 words Report 1870LOncologic therapeutics has evolved enormously as we entered the 21st century. Unfortunately, the treatment of advanced urothelial cancer has remained unchanged over the last two decades despite a better understanding of...

• miRNA-15a/16: as tumor suppressors and more

  Authors:Enyu Huang, Ronghua Liu, and Yiwei ChuFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20158,913 words Report 1640LAuthor(s): Enyu Huang aff1 , Ronghua Liu aff1 , Yiwei Chu [*] aff1 aff2 KEYWORDS angiogenesis; cancer hallmarks; cancer therapy; immune regulator; miRNA MiR-15a and miR-16, identified as a miRNA cluster at...

• Radiotherapy of non-small-cell lung cancer in the era of EGFR gene mutations and EGF receptor tyrosine kinase inhibitors

  Authors:Ilaria Moschini, Cristina Dell'Anna, Pier Luigi Losardo, Paola Bordi, Nunziata D'Abbiero, and Marcello TiseoFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20159,247 words Report 1730LAuthor(s): Ilaria Moschini aff1 , Cristina Dell'Anna aff1 , Pier Luigi Losardo aff1 , Paola Bordi aff2 , Nunziata D'Abbiero aff1 , Marcello Tiseo [*] aff2 KEYWORDS brain radiotherapy; EGFR ; non-small-cell lung...

• Treating operable patients with gastric cancer: Macdonald's protocol versus adjuvant chemotherapy

  Authors:Pedro Nazareth Aguiar, Hakaru Tadokoro, Nora Manoukian Forones, and Ramon Andrade de MelloFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20152,218 words Report 1940LAuthor(s): Pedro Nazareth Aguiar aff1 , Hakaru Tadokoro aff1 , Nora Manoukian Forones aff1 , Ramon Andrade de Mello [*] aff2 aff3 KEYWORDS adjunct chemotherapy; gastric cancer; Macdonald's protocol; operable...

• Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond

  Authors:Gennaro Gadaleta-Caldarola, Rosa Divella, Antonio Mazzocca, Stefania Infusino, Emanuela Ferraro, Gianfranco Filippelli, et al.From:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20152,111 words Report 1730LAuthor(s): Gennaro Gadaleta-Caldarola [*] aff1 , Rosa Divella aff2 , Antonio Mazzocca aff3 aff4 , Stefania Infusino aff5 , Emanuela Ferraro aff6 , Gianfranco Filippelli aff5 , Antonella Daniele aff2 , Carlo Sabbà aff3 ,...

• The future of targeted therapies for brain metastases

  Authors:Anna S Berghoff and Matthias PreusserFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 201510,717 words Report 2040LAuthor(s): Anna S Berghoff aff1 aff2 , Matthias Preusser [*] aff1 aff2 KEYWORDS ALK translocation; anti-HER2 therapy; brain metastases; EGFR mutation; targeted therapies Brain metastases (BM) are an increasing...

• Corrigendum

  From:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 2015351 words Correction notice 1230LFollowing publication of the Research Article by Jose Muñoz-Langa, Javier De Castro, Pere Gascó, Alfredo Sanchez, Emilio Esteban, Jose Manuel Gasent, Isidoro Barneto, Joaquin Montalar, Angel Artal & Sara Vidal titled...

• Feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience

  Authors:Anna M Czarnecka, Maciej Kawecki, Fei Lian, Jan Korniluk, and Cezary SzczylikFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 201511,079 words Report 1810LAuthor(s): Anna M Czarnecka [*] aff1 , Maciej Kawecki aff1 , Fei Lian aff2 , Jan Korniluk aff1 , Cezary Szczylik aff1 KEYWORDS end-stage renal disease; hemodialysis; pazopanib; renal cell cancer; renal...

• Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial

  Authors:Severine Guiu, Celine Charon-Barra, Dewi Vernerey, Pierre Fumoleau, Mario Campone, Marc Spielmann, et al.From:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20158,916 words Report 1800LAuthor(s): Séverine Guiu [*] aff1 , Céline Charon-Barra aff2 , Déwi Vernerey aff3 , Pierre Fumoleau aff4 , Mario Campone aff5 , Marc Spielmann aff6 , Henri Roché aff7 , Christel Mesleard aff8 , Laurent Arnould aff2 ,...

• Present status and future perspectives of ALPPS (associating liver partition and portal vein ligation for staged hepatectomy)

  Authors:Marcello Donati, Francesco Basile, and Karl J OldhaferFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20152,273 words Report 1810LAuthor(s): Marcello Donati [*] aff1 aff2 , Francesco Basile aff1 , Karl J Oldhafer aff2 aff3 KEYWORDS ALPPS; consensus conference; extended hepatectomy; in situ split; liver hypertrophy; liver regeneration; liver...

• Are predictions of cancer response to targeted drugs, based on effects in unrelated tissues, the 'Black Swan' events?

  Authors:Beatrica Kurbel, Ante Zvonimir Golem, and Sven KurbelFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20155,251 words Report 1800LAuthor(s): Beatrica Kurbel aff1 , Ante Zvonimir Golem aff2 , Sven Kurbel [*] aff3 KEYWORDS adverse effects; antineoplastic drugs; prediction markers; targeted drugs It has been well recognized that precise...

• The utility of molecular markers in pre-operative assessment of thyroid nodules

  Authors:Parisha Bhatia, Zakaria Y Abd Elmageed, Paul Friedlander, Rizwan Aslam, and Emad KandilFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20155,846 words Report 1750LAuthor(s): Parisha Bhatia aff1 , Zakaria Y Abd Elmageed aff1 , Paul Friedlander aff2 , Rizwan Aslam aff2 , Emad Kandil [*] aff1 aff2 KEYWORDS biological markers; cytodiagnosis; genetic markers; immunochemistry;...

• Can cardio-oncology deliver better care internationally?

  Authors:Zaza Iakobishvili and Ran KornowskiFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20152,183 words Report 1690LAuthor(s): Zaza Iakobishvili [*] aff1 , Ran Kornowski aff1 KEYWORDS anthracyclines; biomarkers; brain natriuretic peptide; cancer; cardiomyopathy surveillance; cardio-oncology; cardiotoxicity; heart failure;...